Global Imatinib Drug Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Imatinib is a chemotherapy drug that acts by reducing or preventing the progression of cancer cells. This drug is used for the treatment of certain cancers such as chronic myeloid leukemia, acute lymphoblastic leukemia, gastrointestinal tumors, certain skin tumors (dermatofibrosarcoma protuberans), and myelodysplastic/myeloproliferative diseases.
LPI (LP Information)' newest research report, the “Imatinib Drug Industry Forecast” looks at past sales and reviews total world Imatinib Drug sales in 2022, providing a comprehensive analysis by region and market sector of projected Imatinib Drug sales for 2023 through 2029. With Imatinib Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Imatinib Drug industry.
This Insight Report provides a comprehensive analysis of the global Imatinib Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Imatinib Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Imatinib Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Imatinib Drug and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Imatinib Drug.
The global Imatinib Drug market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
Growth in prevalence of cancer, increase in demand for target drug therapy, and patent expiry of imatinib drug are expected to drive the imatinib drug market. Furthermore, rise in healthcare expenditure and increase in awareness of cancer by government and private organizations are anticipated to boost the market growth.
This report presents a comprehensive overview, market shares, and growth opportunities of Imatinib Drug market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Imatinib Drug market?
What factors are driving Imatinib Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Imatinib Drug market opportunities vary by end market size?
How does Imatinib Drug break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Imatinib is a chemotherapy drug that acts by reducing or preventing the progression of cancer cells. This drug is used for the treatment of certain cancers such as chronic myeloid leukemia, acute lymphoblastic leukemia, gastrointestinal tumors, certain skin tumors (dermatofibrosarcoma protuberans), and myelodysplastic/myeloproliferative diseases.
LPI (LP Information)' newest research report, the “Imatinib Drug Industry Forecast” looks at past sales and reviews total world Imatinib Drug sales in 2022, providing a comprehensive analysis by region and market sector of projected Imatinib Drug sales for 2023 through 2029. With Imatinib Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Imatinib Drug industry.
This Insight Report provides a comprehensive analysis of the global Imatinib Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Imatinib Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Imatinib Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Imatinib Drug and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Imatinib Drug.
The global Imatinib Drug market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
Growth in prevalence of cancer, increase in demand for target drug therapy, and patent expiry of imatinib drug are expected to drive the imatinib drug market. Furthermore, rise in healthcare expenditure and increase in awareness of cancer by government and private organizations are anticipated to boost the market growth.
This report presents a comprehensive overview, market shares, and growth opportunities of Imatinib Drug market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Tablets
- Capsules
- Chronic Myelogenous Leukemia
- Gastrointestinal Stromal Tumors
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Novartis
- Glenmark Pharmaceuticals Ltd.
- Sun Pharmaceuticals
- Actavis Generics
- Dr. Reddy's Laboratories
- Teva Pharmaceutical Industries Ltd.
- Sanofi S.A.
- Cipla Inc.
- Apotex Inc.
- Mylan Pharms Inc.
What is the 10-year outlook for the global Imatinib Drug market?
What factors are driving Imatinib Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Imatinib Drug market opportunities vary by end market size?
How does Imatinib Drug break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Imatinib Drug Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Imatinib Drug by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Imatinib Drug by Country/Region, 2018, 2022 & 2029
2.2 Imatinib Drug Segment by Type
2.2.1 Tablets
2.2.2 Capsules
2.3 Imatinib Drug Sales by Type
2.3.1 Global Imatinib Drug Sales Market Share by Type (2018-2023)
2.3.2 Global Imatinib Drug Revenue and Market Share by Type (2018-2023)
2.3.3 Global Imatinib Drug Sale Price by Type (2018-2023)
2.4 Imatinib Drug Segment by Application
2.4.1 Chronic Myelogenous Leukemia
2.4.2 Gastrointestinal Stromal Tumors
2.4.3 Others
2.5 Imatinib Drug Sales by Application
2.5.1 Global Imatinib Drug Sale Market Share by Application (2018-2023)
2.5.2 Global Imatinib Drug Revenue and Market Share by Application (2018-2023)
2.5.3 Global Imatinib Drug Sale Price by Application (2018-2023)
3 GLOBAL IMATINIB DRUG BY COMPANY
3.1 Global Imatinib Drug Breakdown Data by Company
3.1.1 Global Imatinib Drug Annual Sales by Company (2018-2023)
3.1.2 Global Imatinib Drug Sales Market Share by Company (2018-2023)
3.2 Global Imatinib Drug Annual Revenue by Company (2018-2023)
3.2.1 Global Imatinib Drug Revenue by Company (2018-2023)
3.2.2 Global Imatinib Drug Revenue Market Share by Company (2018-2023)
3.3 Global Imatinib Drug Sale Price by Company
3.4 Key Manufacturers Imatinib Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Imatinib Drug Product Location Distribution
3.4.2 Players Imatinib Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR IMATINIB DRUG BY GEOGRAPHIC REGION
4.1 World Historic Imatinib Drug Market Size by Geographic Region (2018-2023)
4.1.1 Global Imatinib Drug Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Imatinib Drug Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Imatinib Drug Market Size by Country/Region (2018-2023)
4.2.1 Global Imatinib Drug Annual Sales by Country/Region (2018-2023)
4.2.2 Global Imatinib Drug Annual Revenue by Country/Region (2018-2023)
4.3 Americas Imatinib Drug Sales Growth
4.4 APAC Imatinib Drug Sales Growth
4.5 Europe Imatinib Drug Sales Growth
4.6 Middle East & Africa Imatinib Drug Sales Growth
5 AMERICAS
5.1 Americas Imatinib Drug Sales by Country
5.1.1 Americas Imatinib Drug Sales by Country (2018-2023)
5.1.2 Americas Imatinib Drug Revenue by Country (2018-2023)
5.2 Americas Imatinib Drug Sales by Type
5.3 Americas Imatinib Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Imatinib Drug Sales by Region
6.1.1 APAC Imatinib Drug Sales by Region (2018-2023)
6.1.2 APAC Imatinib Drug Revenue by Region (2018-2023)
6.2 APAC Imatinib Drug Sales by Type
6.3 APAC Imatinib Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Imatinib Drug by Country
7.1.1 Europe Imatinib Drug Sales by Country (2018-2023)
7.1.2 Europe Imatinib Drug Revenue by Country (2018-2023)
7.2 Europe Imatinib Drug Sales by Type
7.3 Europe Imatinib Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Imatinib Drug by Country
8.1.1 Middle East & Africa Imatinib Drug Sales by Country (2018-2023)
8.1.2 Middle East & Africa Imatinib Drug Revenue by Country (2018-2023)
8.2 Middle East & Africa Imatinib Drug Sales by Type
8.3 Middle East & Africa Imatinib Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Imatinib Drug
10.3 Manufacturing Process Analysis of Imatinib Drug
10.4 Industry Chain Structure of Imatinib Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Imatinib Drug Distributors
11.3 Imatinib Drug Customer
12 WORLD FORECAST REVIEW FOR IMATINIB DRUG BY GEOGRAPHIC REGION
12.1 Global Imatinib Drug Market Size Forecast by Region
12.1.1 Global Imatinib Drug Forecast by Region (2024-2029)
12.1.2 Global Imatinib Drug Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Imatinib Drug Forecast by Type
12.7 Global Imatinib Drug Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Novartis
13.1.1 Novartis Company Information
13.1.2 Novartis Imatinib Drug Product Portfolios and Specifications
13.1.3 Novartis Imatinib Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Novartis Main Business Overview
13.1.5 Novartis Latest Developments
13.2 Glenmark Pharmaceuticals Ltd.
13.2.1 Glenmark Pharmaceuticals Ltd. Company Information
13.2.2 Glenmark Pharmaceuticals Ltd. Imatinib Drug Product Portfolios and Specifications
13.2.3 Glenmark Pharmaceuticals Ltd. Imatinib Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Glenmark Pharmaceuticals Ltd. Main Business Overview
13.2.5 Glenmark Pharmaceuticals Ltd. Latest Developments
13.3 Sun Pharmaceuticals
13.3.1 Sun Pharmaceuticals Company Information
13.3.2 Sun Pharmaceuticals Imatinib Drug Product Portfolios and Specifications
13.3.3 Sun Pharmaceuticals Imatinib Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Sun Pharmaceuticals Main Business Overview
13.3.5 Sun Pharmaceuticals Latest Developments
13.4 Actavis Generics
13.4.1 Actavis Generics Company Information
13.4.2 Actavis Generics Imatinib Drug Product Portfolios and Specifications
13.4.3 Actavis Generics Imatinib Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Actavis Generics Main Business Overview
13.4.5 Actavis Generics Latest Developments
13.5 Dr. Reddy's Laboratories
13.5.1 Dr. Reddy's Laboratories Company Information
13.5.2 Dr. Reddy's Laboratories Imatinib Drug Product Portfolios and Specifications
13.5.3 Dr. Reddy's Laboratories Imatinib Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Dr. Reddy's Laboratories Main Business Overview
13.5.5 Dr. Reddy's Laboratories Latest Developments
13.6 Teva Pharmaceutical Industries Ltd.
13.6.1 Teva Pharmaceutical Industries Ltd. Company Information
13.6.2 Teva Pharmaceutical Industries Ltd. Imatinib Drug Product Portfolios and Specifications
13.6.3 Teva Pharmaceutical Industries Ltd. Imatinib Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Teva Pharmaceutical Industries Ltd. Main Business Overview
13.6.5 Teva Pharmaceutical Industries Ltd. Latest Developments
13.7 Sanofi S.A.
13.7.1 Sanofi S.A. Company Information
13.7.2 Sanofi S.A. Imatinib Drug Product Portfolios and Specifications
13.7.3 Sanofi S.A. Imatinib Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Sanofi S.A. Main Business Overview
13.7.5 Sanofi S.A. Latest Developments
13.8 Cipla Inc.
13.8.1 Cipla Inc. Company Information
13.8.2 Cipla Inc. Imatinib Drug Product Portfolios and Specifications
13.8.3 Cipla Inc. Imatinib Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Cipla Inc. Main Business Overview
13.8.5 Cipla Inc. Latest Developments
13.9 Apotex Inc.
13.9.1 Apotex Inc. Company Information
13.9.2 Apotex Inc. Imatinib Drug Product Portfolios and Specifications
13.9.3 Apotex Inc. Imatinib Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Apotex Inc. Main Business Overview
13.9.5 Apotex Inc. Latest Developments
13.10 Mylan Pharms Inc.
13.10.1 Mylan Pharms Inc. Company Information
13.10.2 Mylan Pharms Inc. Imatinib Drug Product Portfolios and Specifications
13.10.3 Mylan Pharms Inc. Imatinib Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Mylan Pharms Inc. Main Business Overview
13.10.5 Mylan Pharms Inc. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Imatinib Drug Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Imatinib Drug by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Imatinib Drug by Country/Region, 2018, 2022 & 2029
2.2 Imatinib Drug Segment by Type
2.2.1 Tablets
2.2.2 Capsules
2.3 Imatinib Drug Sales by Type
2.3.1 Global Imatinib Drug Sales Market Share by Type (2018-2023)
2.3.2 Global Imatinib Drug Revenue and Market Share by Type (2018-2023)
2.3.3 Global Imatinib Drug Sale Price by Type (2018-2023)
2.4 Imatinib Drug Segment by Application
2.4.1 Chronic Myelogenous Leukemia
2.4.2 Gastrointestinal Stromal Tumors
2.4.3 Others
2.5 Imatinib Drug Sales by Application
2.5.1 Global Imatinib Drug Sale Market Share by Application (2018-2023)
2.5.2 Global Imatinib Drug Revenue and Market Share by Application (2018-2023)
2.5.3 Global Imatinib Drug Sale Price by Application (2018-2023)
3 GLOBAL IMATINIB DRUG BY COMPANY
3.1 Global Imatinib Drug Breakdown Data by Company
3.1.1 Global Imatinib Drug Annual Sales by Company (2018-2023)
3.1.2 Global Imatinib Drug Sales Market Share by Company (2018-2023)
3.2 Global Imatinib Drug Annual Revenue by Company (2018-2023)
3.2.1 Global Imatinib Drug Revenue by Company (2018-2023)
3.2.2 Global Imatinib Drug Revenue Market Share by Company (2018-2023)
3.3 Global Imatinib Drug Sale Price by Company
3.4 Key Manufacturers Imatinib Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Imatinib Drug Product Location Distribution
3.4.2 Players Imatinib Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR IMATINIB DRUG BY GEOGRAPHIC REGION
4.1 World Historic Imatinib Drug Market Size by Geographic Region (2018-2023)
4.1.1 Global Imatinib Drug Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Imatinib Drug Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Imatinib Drug Market Size by Country/Region (2018-2023)
4.2.1 Global Imatinib Drug Annual Sales by Country/Region (2018-2023)
4.2.2 Global Imatinib Drug Annual Revenue by Country/Region (2018-2023)
4.3 Americas Imatinib Drug Sales Growth
4.4 APAC Imatinib Drug Sales Growth
4.5 Europe Imatinib Drug Sales Growth
4.6 Middle East & Africa Imatinib Drug Sales Growth
5 AMERICAS
5.1 Americas Imatinib Drug Sales by Country
5.1.1 Americas Imatinib Drug Sales by Country (2018-2023)
5.1.2 Americas Imatinib Drug Revenue by Country (2018-2023)
5.2 Americas Imatinib Drug Sales by Type
5.3 Americas Imatinib Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Imatinib Drug Sales by Region
6.1.1 APAC Imatinib Drug Sales by Region (2018-2023)
6.1.2 APAC Imatinib Drug Revenue by Region (2018-2023)
6.2 APAC Imatinib Drug Sales by Type
6.3 APAC Imatinib Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Imatinib Drug by Country
7.1.1 Europe Imatinib Drug Sales by Country (2018-2023)
7.1.2 Europe Imatinib Drug Revenue by Country (2018-2023)
7.2 Europe Imatinib Drug Sales by Type
7.3 Europe Imatinib Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Imatinib Drug by Country
8.1.1 Middle East & Africa Imatinib Drug Sales by Country (2018-2023)
8.1.2 Middle East & Africa Imatinib Drug Revenue by Country (2018-2023)
8.2 Middle East & Africa Imatinib Drug Sales by Type
8.3 Middle East & Africa Imatinib Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Imatinib Drug
10.3 Manufacturing Process Analysis of Imatinib Drug
10.4 Industry Chain Structure of Imatinib Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Imatinib Drug Distributors
11.3 Imatinib Drug Customer
12 WORLD FORECAST REVIEW FOR IMATINIB DRUG BY GEOGRAPHIC REGION
12.1 Global Imatinib Drug Market Size Forecast by Region
12.1.1 Global Imatinib Drug Forecast by Region (2024-2029)
12.1.2 Global Imatinib Drug Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Imatinib Drug Forecast by Type
12.7 Global Imatinib Drug Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Novartis
13.1.1 Novartis Company Information
13.1.2 Novartis Imatinib Drug Product Portfolios and Specifications
13.1.3 Novartis Imatinib Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Novartis Main Business Overview
13.1.5 Novartis Latest Developments
13.2 Glenmark Pharmaceuticals Ltd.
13.2.1 Glenmark Pharmaceuticals Ltd. Company Information
13.2.2 Glenmark Pharmaceuticals Ltd. Imatinib Drug Product Portfolios and Specifications
13.2.3 Glenmark Pharmaceuticals Ltd. Imatinib Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Glenmark Pharmaceuticals Ltd. Main Business Overview
13.2.5 Glenmark Pharmaceuticals Ltd. Latest Developments
13.3 Sun Pharmaceuticals
13.3.1 Sun Pharmaceuticals Company Information
13.3.2 Sun Pharmaceuticals Imatinib Drug Product Portfolios and Specifications
13.3.3 Sun Pharmaceuticals Imatinib Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Sun Pharmaceuticals Main Business Overview
13.3.5 Sun Pharmaceuticals Latest Developments
13.4 Actavis Generics
13.4.1 Actavis Generics Company Information
13.4.2 Actavis Generics Imatinib Drug Product Portfolios and Specifications
13.4.3 Actavis Generics Imatinib Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Actavis Generics Main Business Overview
13.4.5 Actavis Generics Latest Developments
13.5 Dr. Reddy's Laboratories
13.5.1 Dr. Reddy's Laboratories Company Information
13.5.2 Dr. Reddy's Laboratories Imatinib Drug Product Portfolios and Specifications
13.5.3 Dr. Reddy's Laboratories Imatinib Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Dr. Reddy's Laboratories Main Business Overview
13.5.5 Dr. Reddy's Laboratories Latest Developments
13.6 Teva Pharmaceutical Industries Ltd.
13.6.1 Teva Pharmaceutical Industries Ltd. Company Information
13.6.2 Teva Pharmaceutical Industries Ltd. Imatinib Drug Product Portfolios and Specifications
13.6.3 Teva Pharmaceutical Industries Ltd. Imatinib Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Teva Pharmaceutical Industries Ltd. Main Business Overview
13.6.5 Teva Pharmaceutical Industries Ltd. Latest Developments
13.7 Sanofi S.A.
13.7.1 Sanofi S.A. Company Information
13.7.2 Sanofi S.A. Imatinib Drug Product Portfolios and Specifications
13.7.3 Sanofi S.A. Imatinib Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Sanofi S.A. Main Business Overview
13.7.5 Sanofi S.A. Latest Developments
13.8 Cipla Inc.
13.8.1 Cipla Inc. Company Information
13.8.2 Cipla Inc. Imatinib Drug Product Portfolios and Specifications
13.8.3 Cipla Inc. Imatinib Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Cipla Inc. Main Business Overview
13.8.5 Cipla Inc. Latest Developments
13.9 Apotex Inc.
13.9.1 Apotex Inc. Company Information
13.9.2 Apotex Inc. Imatinib Drug Product Portfolios and Specifications
13.9.3 Apotex Inc. Imatinib Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Apotex Inc. Main Business Overview
13.9.5 Apotex Inc. Latest Developments
13.10 Mylan Pharms Inc.
13.10.1 Mylan Pharms Inc. Company Information
13.10.2 Mylan Pharms Inc. Imatinib Drug Product Portfolios and Specifications
13.10.3 Mylan Pharms Inc. Imatinib Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Mylan Pharms Inc. Main Business Overview
13.10.5 Mylan Pharms Inc. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Imatinib Drug Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Imatinib Drug Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Tablets
Table 4. Major Players of Capsules
Table 5. Global Imatinib Drug Sales by Type (2018-2023) & (K Units)
Table 6. Global Imatinib Drug Sales Market Share by Type (2018-2023)
Table 7. Global Imatinib Drug Revenue by Type (2018-2023) & ($ million)
Table 8. Global Imatinib Drug Revenue Market Share by Type (2018-2023)
Table 9. Global Imatinib Drug Sale Price by Type (2018-2023) & (USD/Unit)
Table 10. Global Imatinib Drug Sales by Application (2018-2023) & (K Units)
Table 11. Global Imatinib Drug Sales Market Share by Application (2018-2023)
Table 12. Global Imatinib Drug Revenue by Application (2018-2023)
Table 13. Global Imatinib Drug Revenue Market Share by Application (2018-2023)
Table 14. Global Imatinib Drug Sale Price by Application (2018-2023) & (USD/Unit)
Table 15. Global Imatinib Drug Sales by Company (2018-2023) & (K Units)
Table 16. Global Imatinib Drug Sales Market Share by Company (2018-2023)
Table 17. Global Imatinib Drug Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Imatinib Drug Revenue Market Share by Company (2018-2023)
Table 19. Global Imatinib Drug Sale Price by Company (2018-2023) & (USD/Unit)
Table 20. Key Manufacturers Imatinib Drug Producing Area Distribution and Sales Area
Table 21. Players Imatinib Drug Products Offered
Table 22. Imatinib Drug Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Imatinib Drug Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Imatinib Drug Sales Market Share Geographic Region (2018-2023)
Table 27. Global Imatinib Drug Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Imatinib Drug Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Imatinib Drug Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Imatinib Drug Sales Market Share by Country/Region (2018-2023)
Table 31. Global Imatinib Drug Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Imatinib Drug Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Imatinib Drug Sales by Country (2018-2023) & (K Units)
Table 34. Americas Imatinib Drug Sales Market Share by Country (2018-2023)
Table 35. Americas Imatinib Drug Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Imatinib Drug Revenue Market Share by Country (2018-2023)
Table 37. Americas Imatinib Drug Sales by Type (2018-2023) & (K Units)
Table 38. Americas Imatinib Drug Sales by Application (2018-2023) & (K Units)
Table 39. APAC Imatinib Drug Sales by Region (2018-2023) & (K Units)
Table 40. APAC Imatinib Drug Sales Market Share by Region (2018-2023)
Table 41. APAC Imatinib Drug Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Imatinib Drug Revenue Market Share by Region (2018-2023)
Table 43. APAC Imatinib Drug Sales by Type (2018-2023) & (K Units)
Table 44. APAC Imatinib Drug Sales by Application (2018-2023) & (K Units)
Table 45. Europe Imatinib Drug Sales by Country (2018-2023) & (K Units)
Table 46. Europe Imatinib Drug Sales Market Share by Country (2018-2023)
Table 47. Europe Imatinib Drug Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Imatinib Drug Revenue Market Share by Country (2018-2023)
Table 49. Europe Imatinib Drug Sales by Type (2018-2023) & (K Units)
Table 50. Europe Imatinib Drug Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Imatinib Drug Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Imatinib Drug Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Imatinib Drug Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Imatinib Drug Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Imatinib Drug Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Imatinib Drug Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Imatinib Drug
Table 58. Key Market Challenges & Risks of Imatinib Drug
Table 59. Key Industry Trends of Imatinib Drug
Table 60. Imatinib Drug Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Imatinib Drug Distributors List
Table 63. Imatinib Drug Customer List
Table 64. Global Imatinib Drug Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Imatinib Drug Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Imatinib Drug Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Imatinib Drug Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Imatinib Drug Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Imatinib Drug Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Imatinib Drug Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Imatinib Drug Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Imatinib Drug Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Imatinib Drug Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Imatinib Drug Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Imatinib Drug Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Imatinib Drug Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Imatinib Drug Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Novartis Basic Information, Imatinib Drug Manufacturing Base, Sales Area and Its Competitors
Table 79. Novartis Imatinib Drug Product Portfolios and Specifications
Table 80. Novartis Imatinib Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 81. Novartis Main Business
Table 82. Novartis Latest Developments
Table 83. Glenmark Pharmaceuticals Ltd. Basic Information, Imatinib Drug Manufacturing Base, Sales Area and Its Competitors
Table 84. Glenmark Pharmaceuticals Ltd. Imatinib Drug Product Portfolios and Specifications
Table 85. Glenmark Pharmaceuticals Ltd. Imatinib Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 86. Glenmark Pharmaceuticals Ltd. Main Business
Table 87. Glenmark Pharmaceuticals Ltd. Latest Developments
Table 88. Sun Pharmaceuticals Basic Information, Imatinib Drug Manufacturing Base, Sales Area and Its Competitors
Table 89. Sun Pharmaceuticals Imatinib Drug Product Portfolios and Specifications
Table 90. Sun Pharmaceuticals Imatinib Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 91. Sun Pharmaceuticals Main Business
Table 92. Sun Pharmaceuticals Latest Developments
Table 93. Actavis Generics Basic Information, Imatinib Drug Manufacturing Base, Sales Area and Its Competitors
Table 94. Actavis Generics Imatinib Drug Product Portfolios and Specifications
Table 95. Actavis Generics Imatinib Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 96. Actavis Generics Main Business
Table 97. Actavis Generics Latest Developments
Table 98. Dr. Reddy's Laboratories Basic Information, Imatinib Drug Manufacturing Base, Sales Area and Its Competitors
Table 99. Dr. Reddy's Laboratories Imatinib Drug Product Portfolios and Specifications
Table 100. Dr. Reddy's Laboratories Imatinib Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 101. Dr. Reddy's Laboratories Main Business
Table 102. Dr. Reddy's Laboratories Latest Developments
Table 103. Teva Pharmaceutical Industries Ltd. Basic Information, Imatinib Drug Manufacturing Base, Sales Area and Its Competitors
Table 104. Teva Pharmaceutical Industries Ltd. Imatinib Drug Product Portfolios and Specifications
Table 105. Teva Pharmaceutical Industries Ltd. Imatinib Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 106. Teva Pharmaceutical Industries Ltd. Main Business
Table 107. Teva Pharmaceutical Industries Ltd. Latest Developments
Table 108. Sanofi S.A. Basic Information, Imatinib Drug Manufacturing Base, Sales Area and Its Competitors
Table 109. Sanofi S.A. Imatinib Drug Product Portfolios and Specifications
Table 110. Sanofi S.A. Imatinib Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 111. Sanofi S.A. Main Business
Table 112. Sanofi S.A. Latest Developments
Table 113. Cipla Inc. Basic Information, Imatinib Drug Manufacturing Base, Sales Area and Its Competitors
Table 114. Cipla Inc. Imatinib Drug Product Portfolios and Specifications
Table 115. Cipla Inc. Imatinib Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 116. Cipla Inc. Main Business
Table 117. Cipla Inc. Latest Developments
Table 118. Apotex Inc. Basic Information, Imatinib Drug Manufacturing Base, Sales Area and Its Competitors
Table 119. Apotex Inc. Imatinib Drug Product Portfolios and Specifications
Table 120. Apotex Inc. Imatinib Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 121. Apotex Inc. Main Business
Table 122. Apotex Inc. Latest Developments
Table 123. Mylan Pharms Inc. Basic Information, Imatinib Drug Manufacturing Base, Sales Area and Its Competitors
Table 124. Mylan Pharms Inc. Imatinib Drug Product Portfolios and Specifications
Table 125. Mylan Pharms Inc. Imatinib Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 126. Mylan Pharms Inc. Main Business
Table 127. Mylan Pharms Inc. Latest Developments
Table 1. Imatinib Drug Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Imatinib Drug Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Tablets
Table 4. Major Players of Capsules
Table 5. Global Imatinib Drug Sales by Type (2018-2023) & (K Units)
Table 6. Global Imatinib Drug Sales Market Share by Type (2018-2023)
Table 7. Global Imatinib Drug Revenue by Type (2018-2023) & ($ million)
Table 8. Global Imatinib Drug Revenue Market Share by Type (2018-2023)
Table 9. Global Imatinib Drug Sale Price by Type (2018-2023) & (USD/Unit)
Table 10. Global Imatinib Drug Sales by Application (2018-2023) & (K Units)
Table 11. Global Imatinib Drug Sales Market Share by Application (2018-2023)
Table 12. Global Imatinib Drug Revenue by Application (2018-2023)
Table 13. Global Imatinib Drug Revenue Market Share by Application (2018-2023)
Table 14. Global Imatinib Drug Sale Price by Application (2018-2023) & (USD/Unit)
Table 15. Global Imatinib Drug Sales by Company (2018-2023) & (K Units)
Table 16. Global Imatinib Drug Sales Market Share by Company (2018-2023)
Table 17. Global Imatinib Drug Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Imatinib Drug Revenue Market Share by Company (2018-2023)
Table 19. Global Imatinib Drug Sale Price by Company (2018-2023) & (USD/Unit)
Table 20. Key Manufacturers Imatinib Drug Producing Area Distribution and Sales Area
Table 21. Players Imatinib Drug Products Offered
Table 22. Imatinib Drug Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Imatinib Drug Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Imatinib Drug Sales Market Share Geographic Region (2018-2023)
Table 27. Global Imatinib Drug Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Imatinib Drug Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Imatinib Drug Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Imatinib Drug Sales Market Share by Country/Region (2018-2023)
Table 31. Global Imatinib Drug Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Imatinib Drug Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Imatinib Drug Sales by Country (2018-2023) & (K Units)
Table 34. Americas Imatinib Drug Sales Market Share by Country (2018-2023)
Table 35. Americas Imatinib Drug Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Imatinib Drug Revenue Market Share by Country (2018-2023)
Table 37. Americas Imatinib Drug Sales by Type (2018-2023) & (K Units)
Table 38. Americas Imatinib Drug Sales by Application (2018-2023) & (K Units)
Table 39. APAC Imatinib Drug Sales by Region (2018-2023) & (K Units)
Table 40. APAC Imatinib Drug Sales Market Share by Region (2018-2023)
Table 41. APAC Imatinib Drug Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Imatinib Drug Revenue Market Share by Region (2018-2023)
Table 43. APAC Imatinib Drug Sales by Type (2018-2023) & (K Units)
Table 44. APAC Imatinib Drug Sales by Application (2018-2023) & (K Units)
Table 45. Europe Imatinib Drug Sales by Country (2018-2023) & (K Units)
Table 46. Europe Imatinib Drug Sales Market Share by Country (2018-2023)
Table 47. Europe Imatinib Drug Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Imatinib Drug Revenue Market Share by Country (2018-2023)
Table 49. Europe Imatinib Drug Sales by Type (2018-2023) & (K Units)
Table 50. Europe Imatinib Drug Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Imatinib Drug Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Imatinib Drug Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Imatinib Drug Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Imatinib Drug Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Imatinib Drug Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Imatinib Drug Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Imatinib Drug
Table 58. Key Market Challenges & Risks of Imatinib Drug
Table 59. Key Industry Trends of Imatinib Drug
Table 60. Imatinib Drug Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Imatinib Drug Distributors List
Table 63. Imatinib Drug Customer List
Table 64. Global Imatinib Drug Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Imatinib Drug Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Imatinib Drug Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Imatinib Drug Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Imatinib Drug Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Imatinib Drug Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Imatinib Drug Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Imatinib Drug Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Imatinib Drug Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Imatinib Drug Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Imatinib Drug Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Imatinib Drug Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Imatinib Drug Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Imatinib Drug Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Novartis Basic Information, Imatinib Drug Manufacturing Base, Sales Area and Its Competitors
Table 79. Novartis Imatinib Drug Product Portfolios and Specifications
Table 80. Novartis Imatinib Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 81. Novartis Main Business
Table 82. Novartis Latest Developments
Table 83. Glenmark Pharmaceuticals Ltd. Basic Information, Imatinib Drug Manufacturing Base, Sales Area and Its Competitors
Table 84. Glenmark Pharmaceuticals Ltd. Imatinib Drug Product Portfolios and Specifications
Table 85. Glenmark Pharmaceuticals Ltd. Imatinib Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 86. Glenmark Pharmaceuticals Ltd. Main Business
Table 87. Glenmark Pharmaceuticals Ltd. Latest Developments
Table 88. Sun Pharmaceuticals Basic Information, Imatinib Drug Manufacturing Base, Sales Area and Its Competitors
Table 89. Sun Pharmaceuticals Imatinib Drug Product Portfolios and Specifications
Table 90. Sun Pharmaceuticals Imatinib Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 91. Sun Pharmaceuticals Main Business
Table 92. Sun Pharmaceuticals Latest Developments
Table 93. Actavis Generics Basic Information, Imatinib Drug Manufacturing Base, Sales Area and Its Competitors
Table 94. Actavis Generics Imatinib Drug Product Portfolios and Specifications
Table 95. Actavis Generics Imatinib Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 96. Actavis Generics Main Business
Table 97. Actavis Generics Latest Developments
Table 98. Dr. Reddy's Laboratories Basic Information, Imatinib Drug Manufacturing Base, Sales Area and Its Competitors
Table 99. Dr. Reddy's Laboratories Imatinib Drug Product Portfolios and Specifications
Table 100. Dr. Reddy's Laboratories Imatinib Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 101. Dr. Reddy's Laboratories Main Business
Table 102. Dr. Reddy's Laboratories Latest Developments
Table 103. Teva Pharmaceutical Industries Ltd. Basic Information, Imatinib Drug Manufacturing Base, Sales Area and Its Competitors
Table 104. Teva Pharmaceutical Industries Ltd. Imatinib Drug Product Portfolios and Specifications
Table 105. Teva Pharmaceutical Industries Ltd. Imatinib Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 106. Teva Pharmaceutical Industries Ltd. Main Business
Table 107. Teva Pharmaceutical Industries Ltd. Latest Developments
Table 108. Sanofi S.A. Basic Information, Imatinib Drug Manufacturing Base, Sales Area and Its Competitors
Table 109. Sanofi S.A. Imatinib Drug Product Portfolios and Specifications
Table 110. Sanofi S.A. Imatinib Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 111. Sanofi S.A. Main Business
Table 112. Sanofi S.A. Latest Developments
Table 113. Cipla Inc. Basic Information, Imatinib Drug Manufacturing Base, Sales Area and Its Competitors
Table 114. Cipla Inc. Imatinib Drug Product Portfolios and Specifications
Table 115. Cipla Inc. Imatinib Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 116. Cipla Inc. Main Business
Table 117. Cipla Inc. Latest Developments
Table 118. Apotex Inc. Basic Information, Imatinib Drug Manufacturing Base, Sales Area and Its Competitors
Table 119. Apotex Inc. Imatinib Drug Product Portfolios and Specifications
Table 120. Apotex Inc. Imatinib Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 121. Apotex Inc. Main Business
Table 122. Apotex Inc. Latest Developments
Table 123. Mylan Pharms Inc. Basic Information, Imatinib Drug Manufacturing Base, Sales Area and Its Competitors
Table 124. Mylan Pharms Inc. Imatinib Drug Product Portfolios and Specifications
Table 125. Mylan Pharms Inc. Imatinib Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 126. Mylan Pharms Inc. Main Business
Table 127. Mylan Pharms Inc. Latest Developments
LIST OF FIGURES
Figure 1. Picture of Imatinib Drug
Figure 2. Imatinib Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Imatinib Drug Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Imatinib Drug Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Imatinib Drug Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Tablets
Figure 10. Product Picture of Capsules
Figure 11. Global Imatinib Drug Sales Market Share by Type in 2022
Figure 12. Global Imatinib Drug Revenue Market Share by Type (2018-2023)
Figure 13. Imatinib Drug Consumed in Chronic Myelogenous Leukemia
Figure 14. Global Imatinib Drug Market: Chronic Myelogenous Leukemia (2018-2023) & (K Units)
Figure 15. Imatinib Drug Consumed in Gastrointestinal Stromal Tumors
Figure 16. Global Imatinib Drug Market: Gastrointestinal Stromal Tumors (2018-2023) & (K Units)
Figure 17. Imatinib Drug Consumed in Others
Figure 18. Global Imatinib Drug Market: Others (2018-2023) & (K Units)
Figure 19. Global Imatinib Drug Sales Market Share by Application (2022)
Figure 20. Global Imatinib Drug Revenue Market Share by Application in 2022
Figure 21. Imatinib Drug Sales Market by Company in 2022 (K Units)
Figure 22. Global Imatinib Drug Sales Market Share by Company in 2022
Figure 23. Imatinib Drug Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Imatinib Drug Revenue Market Share by Company in 2022
Figure 25. Global Imatinib Drug Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Imatinib Drug Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Imatinib Drug Sales 2018-2023 (K Units)
Figure 28. Americas Imatinib Drug Revenue 2018-2023 ($ Millions)
Figure 29. APAC Imatinib Drug Sales 2018-2023 (K Units)
Figure 30. APAC Imatinib Drug Revenue 2018-2023 ($ Millions)
Figure 31. Europe Imatinib Drug Sales 2018-2023 (K Units)
Figure 32. Europe Imatinib Drug Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Imatinib Drug Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Imatinib Drug Revenue 2018-2023 ($ Millions)
Figure 35. Americas Imatinib Drug Sales Market Share by Country in 2022
Figure 36. Americas Imatinib Drug Revenue Market Share by Country in 2022
Figure 37. Americas Imatinib Drug Sales Market Share by Type (2018-2023)
Figure 38. Americas Imatinib Drug Sales Market Share by Application (2018-2023)
Figure 39. United States Imatinib Drug Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Imatinib Drug Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Imatinib Drug Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Imatinib Drug Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Imatinib Drug Sales Market Share by Region in 2022
Figure 44. APAC Imatinib Drug Revenue Market Share by Regions in 2022
Figure 45. APAC Imatinib Drug Sales Market Share by Type (2018-2023)
Figure 46. APAC Imatinib Drug Sales Market Share by Application (2018-2023)
Figure 47. China Imatinib Drug Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Imatinib Drug Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Imatinib Drug Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Imatinib Drug Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Imatinib Drug Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Imatinib Drug Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Imatinib Drug Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Imatinib Drug Sales Market Share by Country in 2022
Figure 55. Europe Imatinib Drug Revenue Market Share by Country in 2022
Figure 56. Europe Imatinib Drug Sales Market Share by Type (2018-2023)
Figure 57. Europe Imatinib Drug Sales Market Share by Application (2018-2023)
Figure 58. Germany Imatinib Drug Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Imatinib Drug Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Imatinib Drug Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Imatinib Drug Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Imatinib Drug Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Imatinib Drug Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Imatinib Drug Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Imatinib Drug Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Imatinib Drug Sales Market Share by Application (2018-2023)
Figure 67. Egypt Imatinib Drug Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Imatinib Drug Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Imatinib Drug Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Imatinib Drug Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Imatinib Drug Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Imatinib Drug in 2022
Figure 73. Manufacturing Process Analysis of Imatinib Drug
Figure 74. Industry Chain Structure of Imatinib Drug
Figure 75. Channels of Distribution
Figure 76. Global Imatinib Drug Sales Market Forecast by Region (2024-2029)
Figure 77. Global Imatinib Drug Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Imatinib Drug Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Imatinib Drug Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Imatinib Drug Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Imatinib Drug Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Imatinib Drug
Figure 2. Imatinib Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Imatinib Drug Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Imatinib Drug Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Imatinib Drug Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Tablets
Figure 10. Product Picture of Capsules
Figure 11. Global Imatinib Drug Sales Market Share by Type in 2022
Figure 12. Global Imatinib Drug Revenue Market Share by Type (2018-2023)
Figure 13. Imatinib Drug Consumed in Chronic Myelogenous Leukemia
Figure 14. Global Imatinib Drug Market: Chronic Myelogenous Leukemia (2018-2023) & (K Units)
Figure 15. Imatinib Drug Consumed in Gastrointestinal Stromal Tumors
Figure 16. Global Imatinib Drug Market: Gastrointestinal Stromal Tumors (2018-2023) & (K Units)
Figure 17. Imatinib Drug Consumed in Others
Figure 18. Global Imatinib Drug Market: Others (2018-2023) & (K Units)
Figure 19. Global Imatinib Drug Sales Market Share by Application (2022)
Figure 20. Global Imatinib Drug Revenue Market Share by Application in 2022
Figure 21. Imatinib Drug Sales Market by Company in 2022 (K Units)
Figure 22. Global Imatinib Drug Sales Market Share by Company in 2022
Figure 23. Imatinib Drug Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Imatinib Drug Revenue Market Share by Company in 2022
Figure 25. Global Imatinib Drug Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Imatinib Drug Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Imatinib Drug Sales 2018-2023 (K Units)
Figure 28. Americas Imatinib Drug Revenue 2018-2023 ($ Millions)
Figure 29. APAC Imatinib Drug Sales 2018-2023 (K Units)
Figure 30. APAC Imatinib Drug Revenue 2018-2023 ($ Millions)
Figure 31. Europe Imatinib Drug Sales 2018-2023 (K Units)
Figure 32. Europe Imatinib Drug Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Imatinib Drug Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Imatinib Drug Revenue 2018-2023 ($ Millions)
Figure 35. Americas Imatinib Drug Sales Market Share by Country in 2022
Figure 36. Americas Imatinib Drug Revenue Market Share by Country in 2022
Figure 37. Americas Imatinib Drug Sales Market Share by Type (2018-2023)
Figure 38. Americas Imatinib Drug Sales Market Share by Application (2018-2023)
Figure 39. United States Imatinib Drug Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Imatinib Drug Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Imatinib Drug Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Imatinib Drug Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Imatinib Drug Sales Market Share by Region in 2022
Figure 44. APAC Imatinib Drug Revenue Market Share by Regions in 2022
Figure 45. APAC Imatinib Drug Sales Market Share by Type (2018-2023)
Figure 46. APAC Imatinib Drug Sales Market Share by Application (2018-2023)
Figure 47. China Imatinib Drug Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Imatinib Drug Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Imatinib Drug Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Imatinib Drug Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Imatinib Drug Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Imatinib Drug Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Imatinib Drug Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Imatinib Drug Sales Market Share by Country in 2022
Figure 55. Europe Imatinib Drug Revenue Market Share by Country in 2022
Figure 56. Europe Imatinib Drug Sales Market Share by Type (2018-2023)
Figure 57. Europe Imatinib Drug Sales Market Share by Application (2018-2023)
Figure 58. Germany Imatinib Drug Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Imatinib Drug Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Imatinib Drug Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Imatinib Drug Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Imatinib Drug Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Imatinib Drug Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Imatinib Drug Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Imatinib Drug Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Imatinib Drug Sales Market Share by Application (2018-2023)
Figure 67. Egypt Imatinib Drug Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Imatinib Drug Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Imatinib Drug Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Imatinib Drug Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Imatinib Drug Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Imatinib Drug in 2022
Figure 73. Manufacturing Process Analysis of Imatinib Drug
Figure 74. Industry Chain Structure of Imatinib Drug
Figure 75. Channels of Distribution
Figure 76. Global Imatinib Drug Sales Market Forecast by Region (2024-2029)
Figure 77. Global Imatinib Drug Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Imatinib Drug Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Imatinib Drug Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Imatinib Drug Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Imatinib Drug Revenue Market Share Forecast by Application (2024-2029)
